Company Valuation: CME Group

Data adjusted to current consolidation scope
Fiscal Period: September 2020 2021 2022 2023 2024 2025
Market Cap 1 55.26 38.73 44.71 36.17 20.96 18.14
Change - -29.91% 15.43% -19.09% -42.06% -13.47%
Enterprise Value (EV) 1 71.15 53.78 61.51 60.68 41.99 37.37
Change - -24.42% 14.38% -1.35% -30.81% -11%
P/E 650x 22.2x -8.55x -24.7x -8.34x 2.21x
PBR 1.03x 0.67x 0.85x 0.72x 0.44x 0.33x
PEG - 0x 0x 0.3x -0.1x -0x
Capitalization / Revenue 1.89x 9.34x 2.8x 3.08x 0.77x 0.45x
EV / Revenue 2.44x 13x 3.86x 5.16x 1.54x 0.94x
EV / EBITDA 30.6x -59.4x -17.6x 316x -33.1x 18.1x
EV / EBIT 33.3x -42.1x -15.9x -391x -25.7x 19.8x
EV / FCF 21.3x -3.37x -186x - 11.9x 102x
FCF Yield 4.68% -29.6% -0.54% - 8.44% 0.98%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 0.0001 0.001799 -0.005264 -0.001418 -0.002397 0.0068
Distribution rate - - - - - -
Net sales 1 29.17 4.145 15.96 11.76 27.22 39.93
EBITDA 1 2.323 -0.906 -3.489 0.1922 -1.267 2.069
EBIT 1 2.136 -1.278 -3.869 -0.155 -1.635 1.886
Net income 1 0.178 2.502 -5.148 -1.449 -2.502 8.406
Net Debt 1 15.89 15.04 16.8 24.5 21.02 19.23
Reference price 2 0.0650 0.0400 0.0450 0.0350 0.0200 0.0150
Nbr of stocks (in thousands) 8,50,211 9,68,328 9,93,564 10,33,564 10,48,064 12,09,126
Announcement Date 30/10/20 29/10/21 31/10/22 30/01/24 27/01/25 30/01/26
1MYR in Million2MYR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 29.78L
24.34x4.18x18.68x0.95% 30TCr
36.44x5.63x30.66x0.99% 18TCr
14.99x1.15x7.34x4.95% 6.4TCr
17.4x1.47x11.99x3.17% 5.39TCr
30.59x4.3x17.92x0.43% 4.79TCr
14.09x1.45x8.31x3.07% 3.56TCr
11.11x1.05x10.46x4.7% 3.45TCr
30.56x4.44x17.67x1.64% 2.9TCr
12.62x0.42x4.28x3.9% 2.66TCr
Average 21.35x 2.68x 14.14x 2.65% 7.67TCr
Weighted average by Cap. 25.03x 3.69x 18.61x 1.81%

Y-o-Y evolution of P/E

Valuation ratios - P/E - CME Group

Historical PBR trend

Valuation ratios - PBR - CME Group

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - CME Group

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - CME Group